Results of up to 2 years of entecavir vs lamivudine therapy in nucleoside-naïve HBeAg-positive patients with chronic hepatitis B
T.-T. Chang, Y.-C. Chao, V. V. Gorbakov, K.-h. Han, R. G. Gish, R. De Man, H. Cheinquer, F. Bessone, H. Brett-Smith, R. TamezVolume:
16
Year:
2009
Language:
english
Pages:
6
DOI:
10.1111/j.1365-2893.2009.01142.x
File:
PDF, 145 KB
english, 2009